| Name | Title | Contact Details |
|---|---|---|
Allisyn Monteleone |
Associate General Counsel | Profile |
Arya Sadeghi |
Senior Counsel | Profile |
Laura Brake |
Associate General Counsel | Profile |
Matt Bennett |
Head of Sales, Teliso-V | Profile |
Paul Hammond |
Associate General Counsel | Profile |
Womens International Pharmacy is a Madison, WI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Health Network is a Cranston, RI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Vision RT is the inventor of Surface Guided Radiation Therapy (SGRT) and produces a range of innovative solutions to improve radiation therapy.
ISTA Pharmaceuticals, Inc. is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
OPKO Health is a diversified healthcare company that seeks to establish industry leading positions in large, rapidly growing markets. Our diagnostics business includes BioReference Laboratories, the nation`s third largest clinical laboratory with a core genetic testing business and a 400 person sales and marketing team to drive growth and leverage new products, including the 4Kscore® prostate cancer test and the Claros® 1 in office immunoassay platform. Our pharmaceutical business features RAYALDEE, an FDA approved treatment for SHPT in stage 3-¬4 CKD patients with vitamin D insufficiency (launched in November 2016), VARUBITM for chemotherapy induced nausea and vomiting (oral formulation launched by partner TESARO and IV formulation pending FDA approval), OPK88004, a once or twice weekly oxyntomodulin for type 2 diabetes and obesity, in Phase 2 clinical trials, among the new class of GLP-¬1 glucagon receptor dual agonists, and OPK88003, a selective androgen receptor modulator for benign prostatic hyperplasia (Phase 2). Our biologics business includes hGH-¬CTP, a once weekly human growth hormone in Phase 3 and partnered with Pfizer; and a long-¬acting Factor VIIa drug for hemophilia in Phase 2a.